UNUSED state-of-the-art highly flexible small molecule manufacturing facility constructed in 2011 The facility is capable of producing around 400kg of API per year, allowing for the production of batches from lead to candidate through to Phase III and commercial launch quantities. This is the potential capacity, in a configuration of people working in 2x7h on 5 days, but this tool could be operated on a 24x7 basis if needed, in which case higher levels of output could be achieved. Production capacity remains dependent on the type and number of synthesis steps.
PILOT PLANT • Designed to produce GMP active ingredient batches • 15 reactors (from 100 to 1600 liters) and 5 finishing units (from 10 to 100 kg)